World-wide experience with the use of two-directional cavopulmonal anastomosis (TDCPA) for the surgical treatment of congenital heart failure (CHF) is summarized together with the results of analysis of immediate and late outcomes of this operation. It is concluded that TDCPA in certain complex forms of CHF and in patients at risk of poor outcome of Fontan surgery may be used as the final stage of hemodynamic correction.